Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth

• Main Authors: Ong, H.-T., Federspiel, M.J., Guo, C.M., Ooi, L.L., Russell, S.J., Peng, K.-W., Hui, K.M.
• 其他作者: DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
• 格式: Article
• 出版: 2014
• 主題: Hepatocellular carcinoma; Human neutralizing antibody; Mesenchymal stem cells as cell delivery vehicles; Oncolytic measles virus; Orthotopically implanted HCC tumor model; Systemic virotherapy
• 在線閱讀: http://scholarbank.nus.edu.sg/handle/10635/110294

10.1016/j.jhep.2013.07.010